Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.
Neuraptive Therapeutics has raised $7.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
Neuraptive Therapeutics's investors include Ben Franklin Technology Partners, New Rhein, Central Texas Angel Network.
Neuraptive Therapeutics is headquartered in Lafayette, United States.
Neuraptive Therapeutics is a medical technology company that brings novel products to patients with peripheral nerve injuries.
Neuraptive Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuraptive Therapeutics — Funding & Investors." VCBacked, October 25, 2022, https://www.vcbacked.co/company/neuraptive-therapeutics. Accessed September 30, 2026.
VCBacked. (2022). Neuraptive Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/neuraptive-therapeutics
{{cite web |title=Neuraptive Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neuraptive-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated